Ultralife Corporation (ULBI)
| Previous close | 9.30 |
| Open | 9.30 |
| Bid | 9.11 x 100 |
| Ask | 9.19 x 100 |
| Day's range | 9.09 - 9.30 |
| 52-week range | 6.36 - 13.39 |
| Volume | |
| Avg. volume | 69,095 |
| Market cap | 151.937M |
| Beta (5Y monthly) | 0.97 |
| PE ratio (TTM) | 15.23 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Integer Holdings Corporation to Divest Non-Medical Business for $50 million
~ Planned Electrochem divestiture makes Integer a pure-play medical technology company ~PLANO, Texas, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading medical device contract development and manufacturing organization (CDMO), today announced it has entered into an agreement to divest its Electrochem business, which focuses on non-medical applications for the energy, military and environmental sectors, to Ultralife Corporation (NASDAQ: ULBI). Ultralife is ac
- GlobeNewswire
Ultralife Corporation to Acquire Electrochem Solutions, Inc.
Acquisition to Drive Profitability through Increased Scale and Achievable Opportunities for Gross Margin ExpansionNEWARK, N.Y., Sept. 30, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) has signed a stock purchase agreement to acquire all outstanding shares of Electrochem Solutions, Inc. (“Electrochem”) to include its state-of-the-art ISO certified technology and manufacturing facility for $50.0 million in cash from Integer Holdings Corporation (NYSE: ITGR), subject to customary wo
- GlobeNewswire
Ultralife Corporation Reports Second Quarter Results
NEWARK, N.Y., July 25, 2024 (GLOBE NEWSWIRE) -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2024 with the following highlights: Sales of $43.0 million compared to $42.7 million for the 2023 second quarter, including 8.3% growth in Battery & Energy Products sales to its highest level in the Company’s history for this segmentGross profit of $11.6 million, or 26.9% of revenue, compared to $10.6 million, or 24.8% of revenue, for the 2023 seco
